20313 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil 1-aryl substituted, e.g. piretanide
DEUTERATED ORGANIC COMPOUNDS AND USES THEREOF
#2COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
#3SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORS
#4PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING RENAL CYSTIC CILIOPATHY
#5USE OF SMALL-MOLECULE COMPOUND HAVING NAPHTHYLAMINE STRUCTURE
#6Combination Treatment Of Arthritic Disease
#7Compounds and Pharmaceutical Compositions Useful for Managing Sickle Cell Disease and Conditions Related Thereto
#8RESOMELAGON AND ITS DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISEASE, HYPERTENSION AND ATHEROSCLEROSIS
#9A COMBINATION FOR TREATING A RETINAL DISEASE
#10INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF
#11PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING RENAL CYSTIC CILIOPATHY
#12DEUTERATED ORGANIC COMPOUNDS AND USES THEREOF
#13ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS AND USE THEREOF
#14NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME
#15DEUTERATED FUNCTIONALIZED DERIVATIVES OF alpha-ALANINE, IN PARTICULAR FOR THE TREATMENT OF NEUROLOGICAL DISEASES
#16SMALL MOLECULE DRUGS THAT REDUCE PROTEIN AGGREGATION
#17Small molecule inhibitors of lanosterol synthase
#18TREATMENT OF RHEUMATOID ARTHRITIS
#19DEUTERATED ORGANIC COMPOUNDS AND USES THEREOF
#20PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS
#21MITOFUSIN ACTIVATORS AND USES THEREOF
#22Polymorphs of phenyl pyrrole aminoguandium salts
#23SUBSTITUTED PHENETHYLAMINE FOR TREATING INFLAMMATION AND PSYCHOLOGICAL DISORDERS
#24MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE
#25SUSTAINED RELEASE FORMULATIONS COMPRISING A SELECTIVE ANDROGEN RECEPTOR MODULATOR
#26COMBINATION THERAPIES USING IMMUNO-DASH INHIBITORS AND PGE2 ANTAGONISTS
#27NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME
#28INTERMITTENT DOSING OF MDM2 INHIBITOR
#29Small molecule compounds having naphthylamine structure and application thereof
#30VORUCICLIB DOSING REGIMENS AND METHODS OF TREATMENT INCLUDING THE SAME
#31COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES
#32DASH INHIBITORS, AND USES RELATED THERETO
#33OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
#34METHOD OF PREVENTING AND TREATING TYPE 1 DIABETES, ALLOGRAFT REJECTION AND LUNG FIBROSIS (BY TARGETING THE ATP/P2X7R AXIS)
#35TREATMENT OF SYMPTOMATIC VIRAL DISEASES
#36Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms
#37MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES
#38RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF
#39PHENYL PYRROLE AMINOGUANIDINE SALTS AND FORMULATIONS
#40INTERMITTENT DOSING OF MDM2 INHIBITOR
#41PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON NON-HUMAN ORGANISMS
#42COMPOUNDS
#43Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators
#44Method against severe acute respiratory syndrome coronavirus 2 infection
#45TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT
#46INTERMITTENT DOSING OF MDM2 INHIBITOR
#47USE OF T-TYPE CALCIUM CHANNEL BLOCKER FOR TREATING PRURITUS
#48Combination treatment of arthritic disease
#49COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING DEPRESSION
#50Combination therapies using immuno-dash inhibitors and PGE2 antagonists
#51Benzathine analogs
#52Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
#53ANTI-NEOPLASTIC COMPOUNDS AND METHODS TARGETING QSOX1
#54TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
#55Intermittent dosing of MDM2 inhibitor
#56Selective androgen receptor modulators (SARMs) and uses thereof
#57Mitofusin activators and uses thereof
#58Compounds and methods for inducing chondrogenesis
#59Chemical compounds as antibiotics
#60Benzathine analogs
#61Methods and compositions for the inhibition of PIN1
#62OLIGOMER-OPIOID AGONIST CONJUGATES
#63Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk
#64Combination therapies using immuno-dash inhibitors and PGE2 antagonists
#65Methods and compositions for modulating hormone levels
#66Type III deiodinase inhibitors and uses thereof
#67Prodrugs of cytotoxic active agents having enzymatically cleavable groups
#68Method of treatment
#69Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms
#70Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
#71OLIGOMER-OPIOID AGONIST CONJUGATES
#72Lactams for use in the treatment of skin lesions
#73Use of Sigma-1 receptor agonist compounds
#74INTERMITTENT DOSING OF MDM2 INHIBITOR
#75Dash inhibitors, and uses related thereto
#76TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT
#77Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis)
#78Methods, compounds, and compositions for anesthesia
#79Benzathine analogs
#80Compositions comprising at least one dispersed active principle and lipid microcapsules
#81FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
#82Oligomer-opioid agonist conjugates
#83Selective androgen receptor modulators (SARMs) and uses thereof
#84Tetrahydronaphthalene derivative
#85ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF
#86Anti-neoplastic compounds and methods targeting QSOX1
#87Inhibitors of -linked glycosylation and methods using same
#88PPAR-alpha agonist treatment of neuropsychiatric disorders
#89Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#90Phenyl-(aza)cycloalkyl carboxylic acid GPR120 modulators
#91Pharmaceutical composition containing an arylalkylamine compound
#92No-rinse chemical foam containing trifarotene, and use thereof in the treatment of ichthyosis
#93No-rinse chemical foam containing trifarotene, and use thereof in the treatment of acne
#94Farnesoid X receptor agonists and uses thereof
#95Type III deiodinase inhibitors and uses thereof
#96ROR-gamma modulators and uses thereof
#97Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles
#98Inhibitors of histone deacetylase
#99Monocyclic compound
#100Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
#101Pharmaceutical formulation comprising sembragiline
#102GLP-1 receptor modulators
#103INHIBITORS OF HISTONE DEACETYLASE
#104Pyrrole sulfonyl derivative, preparation method and medical use thereof
#105Method of preventing or treating a pulmonary disease or condition
#106PHENYL-(AZA)CYCLOALKYL CARBOXYLIC ACID GPR120 MODULATORS
#107Anti-ar agent and radiation therapy for androgen receptor positive cancer
#108Methods of reducing mammographic breast density and/or breast cancer risk
#109Methods and compositions for the inhibition of Pin1
#1103,5,N-TRIHYDROXY-ALKANAMIDE OR 3,5,N-TRIHYDROXY-6-ALKENAMIDE DERIVATIVE ALONE OR IN COMBINATION WITH CHEMOTHERAPEUTIC AGENT FOR TREATING CANCER
#111Thiazolidinone compounds and use thereof
#112Methods of use and combinations
#113CDC25A inhibitor for the treatment of drug resistant cancer or for the prevention of tumor relapse
#114Selective androgen receptor modulators (SARMs) and uses thereof
#115Antifungal agents and uses thereof
#116INHIBITORS OF HISTONE DEACETYLASE
#117Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease
#118Process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
#119NOVEL ESTROGEN RECEPTOR LIGANDS
#120Small molecule efflux pump inhibitors
#121Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#122METHODS FOR INHIBITING THE DEVELOPMENT, FORMATION AND/OR MATURATION OF BACTERIAL AND FUNGAL BIOFILMS
#123Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
#124Oligomer-opioid agonist conjugates
#125Antiviral compounds and uses thereof
#126Inhibitors of histone deacetylase
#127Use of Sigma-1 receptor agonist compounds
#128Methods and compositions for modulating hormone levels
#129Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use of same in dermatology
#130Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics
#131Inhibitors of histone deacetylase
#132Benzathine analogs
#133FBXO3 inhibitors
#134GLP-1 receptor modulators
#135ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS
#136Use for PAI-1 inhibitor
#137EphA4 inhibitors as neuroprotective agents
#138Oligomer-opioid agonist conjugates
#139Cyclopropaneamine compound
#140Antiviral compounds and methods of use thereof
#141Small molecule RNase inhibitors and methods of use
#142Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis)
#143NOVEL PYRROLE DERIVATIVES
#144Compounds and methods for inducing chondrogenesis
#145Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#146Selective androgen receptor modulators (SARMS) and uses thereof
#147Inhibitors of histone deacetylase
#148USP14 inhibitors for treating or preventing viral infections
#149Methods and compositions involving RAD51 inhibitors
#150Hepatitis C virus inhibitors
#151Small molecule RNase inhibitors and methods of use
#152Hematopoietic growth factor mimetic small molecule compounds and their uses
#153Oligomer-opioid agonist conjugates
#154Method of treating and preventing brain impairment using Na-K-2Cl-cotransporter isoform 1 inhibitors
#155MICROCAPSULES CONTAINING RETINOIDS, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
#156Benzathine analogs
#157Topical compositions of aqueous gel type in the form of a homogeneous suspension of an active principle of the retinoid class containing at least one hydrophobic silica
#158O/W-emulsion-type topical pharmaceutical compositions containing a retinoid
#159Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease
#160Methods and compositions for the inhibition of Pin1
#161Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#162Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology
#163Oligomer-opioid agonist conjugates
#164Amino-derivatives as novel inhibitors of histone deacetylase
#165Compounds and methods for treating cancer by inhibiting the urokinase receptor
#166ArylSulfonamide-based matrix metalloprotease inhibitors
#167Cyclic amides as MetAP-2 inhibitors
#168Selective androgen receptor modulators (SARMs) and uses thereof
#169Nanodrug targeting protein geranylgeranylation
#170Compounds and methods for inducing chondrogenesis
#171Small molecule inhibitors of Mcl-1 and the uses of thereof
#172Cyclopropaneamine compound
#173Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#174POLYPHENOL ANALOGS TO TREAT ISCHEMIA
#175HDAC inhibitors and therapeutic methods using the same
#176Methods for treating HCV
#177Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
#178Methods and compositions for modulating P300/CBP activity
#179Topical compositions containing a retinoid of the oil-in-water emulsion type
#180PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR
#181Small molecule RNase inhibitors and methods of use
#182Small molecule RNase inhibitors and methods of use
#183Method for preventing or treating skin tumor
#184Formulation for the prevention of cardiovascular disease
#185Diaminocyclohexane compounds and uses thereof
#186Selective androgen receptor modulators (SARMs) and uses thereof
#187Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle Toxicity
#188ANTIMETASTATIC COMPOUNDS
#189Methods for treating HCV
#190Inhibitors of influenza endonuclease activity and tools for their discovery
#191METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS, AND TUMOR-RELATED DISORDERS
#192COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#193Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
#194Hematopoietic growth factor mimetic small molecule compounds and their uses
#195Oligomer-opioid agonist conjugates
#1965-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
#197METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION
#198Oligomer-opioid agonist conjugates
#199Arylsulfonamide based matrix metalloprotease inhibitors
#200Amino-derivatives as novel inhibitors of histone deacetylase
#201Oligomer-opioid agonist conjugates
#202Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
#203AMINOCARBONYL-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE
#204Sulfonyl-derivatives as novel inhibitors of histone deacetylase
#205Antiviral compounds and uses thereof
#206THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
#207THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND ANTI-HER2(ERBB2) ANTIBODIES OR COMBINATIONS OF COX-2 INHIBITORS AND HER2(ERBB2) RECEPTOR TYROSINE KINASE INHIBITORS
#208Carbonylamino-derivatives as novel inhibitors of histone deacetylase
#209THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS
#210Selective androgen receptor modulators (SARMs) and uses thereof
#211COMBINATION THERAPY FOR THE TREATMENT OF CANCER USING COX-2 INHIBITORS AND DUAL InHIBITORS OF EGFR [ErbB1] AND HER-2 [ErbB2]
#212METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS, AND TUMOR-RELATED DISORDERS
#213Therapies for Treating Cancer Using Combinations of COX-2 Inhibitors and Antimetabolites
#214SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
#215Treatment Of Neurological Disorders Using Huperzine
#216Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#217Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#218Methods for treatment of kallikrein-related disorders
#219USE OF AMINOPEPTIDASE INHIBITORS OR AZAINDOLE COMPOUNDS FOR PREVENTING OR TREATING CANCEROUS METASTASES FROM EPITHELIAL ORIGIN
#220MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS
#221NPY Y5 ANTAGONIST
#222Arylsulfonamide-based matrix metalloprotease inhibitors
#223NPY Y5 antagonist
#224SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF
#225Sulfonyl-derivatives as novel or histone deacetylase
#226Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
#2275-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
#228Methods and compositions for modulating P300/CBP activity
#229MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
#230Inhibitors of pyruvate kinase and methods of treating disease
#231Oligomer-opioid agonist conjugates
#232Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
#233Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
#234Inhibitors of histone deacetylase
#235Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
#236THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
#237Substituted gamma lactams as therapeutic agents
#238AMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE
#239Inhibitors of histone deacetylase
#240Inhibitors of histone deacetylase
#241Combination Therapy
#242Merged ion channel modulating compounds and uses thereof
#243Carbonylamino-derivatives as novel inhibitors of histone deacetylase
#244Novel Pharmaceutical
#245Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
#246Agent for preventing or treating neuropathy
#247Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
#248Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
#249MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES
#250Sulfonyl-derivatives as novel inhibitors or histone deacetylase
#251Therapeutic Adjuncts to Enhance the Organ Protective Effects of Postconditioning
#252CONTROLLED RELEASE TABLET FORMULATIONS FOR THE PREVENTION OF ARRHYTHMIAS
#253Substituted gamma lactams as therapeutic agents
#254Substituted gamma lactams as therapeutic agents
#255USE OF CERTAIN BIPHENYL COMPOUNDS FOR PROTECTION OF NEURONS AND OLIGODENDROCYTES IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
#256Alkoxyphenylpropanoic acid derivatives
#257Sulfonyl-derivatives as novel inhibitors of histone deacetylase
#258Benzene compounds
#259Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
#260NPY Y5 antagonist
#2611,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators
#262Inhibitors against the activation of ap-1 and nfat
#263Remedies for neurodegenerative diseases
#264Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders
#265Immunity-related protein kinase inhibitors
#266Agent for preventing or treating neuropathy
#267Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
#268Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
#269Piperazinyl-, piperidinyl- and morpholinyl-derivatives as inhibitors of histone deacetylase
#270Carbonylamino-derivatives as novel inhibitors of histone deacetylase
#271Amino-derivatives as novel inhibitors of histone deacetylase
#272Sulfonyl-Derivatives as novel inhibitors of histone deacetylase
#273Inhibitors of histone deacetylase
#274Inhibitors of histone deacetylase
#275Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
#276Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
#277Pharmaceutical compositions and methods for treating Alzheimer's disease
#278Materials and methods for inhibiting mamalian S-nitrosoglutathione reductase